Approval · Notice of Compliance 3658 · 1997
GAVISCON PREVENT: Notice of Compliance 3658
Issued December 15, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3658
- Date
- December 15, 1997
- Company
- Smithkline Beecham Pharma, Division Of Smithkline Beecham Inc.Mississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- Product name change
- Therapeutic class
- Histamine H2-receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GAVISCON PREVENT | 02237010 | Cancelled Post Market |
Medicinal ingredients
- CIMETIDINE 100 MG per TAB